Allergy
Dr. Reddy’s launches private label version of allergy remedy Xyzal
The Xyzal generic equivalent is an over-the-counter antihistamine used for 24-hour relief of allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing.
Allergy
DSN Retail Excellence Awards — OTC
This month, Drug Store News’ Retail Excellence Awards recognize the exceptional leaders in their field who are disrupting the OTC world.
Allergy
A healthy GSK Consumer may not need Pfizer infusion
Pfizer's consumer health division is expected to sell for as much as $20 billion, according to reports.
Allergy
NIH maps indoor allergens prevelance nationwide
Allergens are widespread, but highly variable in U.S. homes, according to the nation’s largest indoor allergen study to date. Researchers from the National Institutes of Health on Thursday reported that more than 90% of homes had three or more detectable allergens, and 73% of homes had at least one allergen at elevated levels.
Allergy
Innovus launches low-cost nasal spray allergy relief in FlutiCare
Earlier this month Innovus Pharmaceuticals launched FlutiCare OTC in the U.S., making it the third branded fluticasone propionate nasal spray on the market. Innovus, based in San Diego, secured distribution through more than 10,000 independent pharmacies through AmerisourceBergen and McKesson and Walmart online. As a second phase of its launch, Innovus Pharma will launch FlutiCare to large retail stores.
Allergy
GSK ready to kick the tires of any Pfizer OTC divestiture
LONDON — If Pfizer follows through with its announcement last week to potentially place its consumer business up for sale, GlaxoSmithKline, presently the third-largest OTC seller in the U.S. marketplace, would certainly take a look at it, the company's CEO shared Wednesday morning.Load More
Loading Post Please Wait...